These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1362 related articles for article (PubMed ID: 33188364)

  • 1. COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
    Lim S; Bae JH; Kwon HS; Nauck MA
    Nat Rev Endocrinol; 2021 Jan; 17(1):11-30. PubMed ID: 33188364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
    Shao S; Yang Q; Pan R; Yu X; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 and Diabetes Mellitus: From Pathophysiology to Clinical Management.
    Memon SS; Biswas DA
    Cureus; 2022 Nov; 14(11):e31895. PubMed ID: 36579192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Filardi T; Morano S
    J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications.
    Drucker DJ
    Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32294179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes and COVID-19: a major challenge in pandemic period?
    Chakraborty C; Sharma AR; Bhattacharya M; Sharma G; Agoramoorthy G; Lee SS
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11409-11420. PubMed ID: 33215463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.
    Hoevenaar M; Goossens D; Roorda J
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320979097. PubMed ID: 33283602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential therapeutic combination for treatment of COVID-19: Synergistic effect of DPP4 and RAAS suppression.
    Phyu Khin P; Cha SH; Jun HS; Lee JH
    Med Hypotheses; 2020 Nov; 144():110186. PubMed ID: 33254506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network.
    Gao Q; Zhang W; Li T; Yang G; Zhu W; Chen N; Jin H
    Sci Rep; 2022 Jan; 12(1):188. PubMed ID: 34996987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
    Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD
    J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Molecular Evidence Related to COVID-19 in Patients with Diabetes Mellitus.
    Liao YH; Zheng JQ; Zheng CM; Lu KC; Chao YC
    J Clin Med; 2020 Dec; 9(12):. PubMed ID: 33297431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB.
    Rico-Mesa JS; White A; Anderson AS
    Curr Cardiol Rep; 2020 Apr; 22(5):31. PubMed ID: 32291526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of Type 2 Diabetes in Patients with SARS-CoV-2 Infection.
    Bielka W; Przezak A; Pawlik A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors and Coronavirus Disease 2019 (COVID-19).
    Albashir AAD
    South Med J; 2021 Jan; 114(1):51-56. PubMed ID: 33398362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.